Marksans Pharma Allots 56,250 Equity Shares Under ESOP Scheme 2024
Marksans Pharma Ltd 路 Others (Uncategorized) 路 04 Nov 2026, 10:26 pm
Marksans Pharma Allots 56,250 Equity Shares Under ESOP Scheme 2024 Marksans Pharma Limited announced that its Nomination and Remuneration Committee approved the allotment of 56,250 fully paid-up equity shares (face value Re. 1 each) on 4th Nov'26. The allotment was executed upon the exercise of vested options by eligible grantees under the Marksans Employees Stock Option Scheme 2024. The newly issued equity shares will rank pari passu with the company's existing equity shares across all respects.
Original exchange filing (PDF)
More announcements from Marksans Pharma Ltd
- Transcript of Investors/Analyst meet on Q2 FY27 Financial Results 路 13 Nov 2026
- Audio Recording of investor(s)/analyst(s) meet Conference Call on Q2 FY 27 Financial Results 路 05 Nov 2026
- Press Release for Financial Results Q2FY27 路 04 Nov 2026
- Investor Presentation Q2FY27 路 04 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30 September 2026 路 04 Nov 2026
- Marksans Pharma Limited has submitted to the Exchange, unaudited financial results for the quarter and half year ended September 30, 2026. 路 04 Nov 2026
- Please find attached outcome of the Board meeting held on 04 November 2026 路 04 Nov 2026
- Intimation of schedule for Q2FY27 Earnings Conference Call 路 05 Nov 2026
